71 related articles for article (PubMed ID: 11340609)
1. Genetic predisposition and treatment-related leukemia.
Perentesis JP
Med Pediatr Oncol; 2001 May; 36(5):541-8. PubMed ID: 11340609
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications.
Kelly KM; Perentesis JP;
Ann Oncol; 2002; 13 Suppl 1():34-9. PubMed ID: 12078900
[TBL] [Abstract][Full Text] [Related]
4. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
Zhu R; Xia Z
Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia.
Pakakasama S; Mukda E; Sasanakul W; Kadegasem P; Udomsubpayakul U; Thithapandha A; Hongeng S
Am J Hematol; 2005 Jul; 79(3):202-5. PubMed ID: 15981231
[TBL] [Abstract][Full Text] [Related]
7. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
8. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk.
Reszka E; Wasowicz W
Int J Occup Med Environ Health; 2001; 14(2):99-113. PubMed ID: 11548073
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
11. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
13. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression.
Bolufer P; Barragan E; Collado M; Cervera J; López JA; Sanz MA
Leuk Res; 2006 Dec; 30(12):1471-91. PubMed ID: 17023046
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitis.
Kim JS; Park JY; Chung WY; Choi MA; Cho KS; Park KK
J Clin Periodontol; 2004 Nov; 31(11):959-64. PubMed ID: 15491310
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
17. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of toxic reactions to drugs and chemicals.
Cascorbi I
Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
